Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04404439
PHASE4

Treatment of Tinnitus With Migraine Medications

Sponsor: University of California, Irvine

View on ClinicalTrials.gov

Summary

Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. In addition, it contributes significant costs to the healthcare system. However, the mechanisms of tinnitus are poorly understood. and there is currently no FDA-approved medication to treat this condition. Current pharmacological treatment options address the stress, anxiety, and depression that are caused by tinnitus. There is an increased evidence of an epidemiological and mechanistic association between tinnitus and migraine. Therefore, in this study, we intended to evaluate the effectiveness of two combinations of migraine medications on patients with moderate to severe tinnitus by comparing them to placebo.

Official title: Treatment of Tinnitus With Migraine Medications: A Randomized Clinical Trial

Key Details

Gender

All

Age Range

25 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

78

Start Date

2019-09-26

Completion Date

2023-12-30

Last Updated

2026-04-16

Healthy Volunteers

No

Interventions

DRUG

Nortriptyline + Topiramate

Group NT

DRUG

Verapamil + Paroxetine

Group VP

DRUG

Placebo

Group P

Locations (1)

University of California, Irvine Medical Center ENT Clinic (Pavilion 2)

Orange, California, United States